Geode Capital Management, LLC Lava Therapeutics Nv Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Geode Capital Management, LLC holds 16,164 shares of LVTX stock, worth $20,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,164
Previous 11,124
45.31%
Holding current value
$20,689
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LVTX
# of Institutions
23Shares Held
3.36MCall Options Held
100Put Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.66 Million0.16% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$987,9980.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3126KShares$161,6990.03% of portfolio
-
Pathway Financial Advisors LLC103KShares$131,2000.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$83,2000.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $33M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...